Precision English for Rare-Disease Pathways: US ODD vs EU ODD significant benefit language differences—crafting conflict‑free claims
Struggling to craft "significant benefit" claims that survive both FDA and EMA scrutiny? By the end of this short, focused lesson you will be able to draft conflict‑free, agency‑appropriate claims by applying a five‑part checklist (population, comparator, claimed benefit, evidence linkage, and certainty qualifier). You’ll get a concise regulatory framing, sentence‑level templates and real‑doc examples, plus practice exercises and revision checklists to convert promotional wording into precise, defensible language—executive, NDA‑ready, and ready for redline.
Read lesson